GCase activity was lower in the CSF of patients with PD carrying a GBA mutation (GBA-PD) compared with that in the CSF of patients with sporadic PD (sPD); moreover, GBA-PD with severe mutations showed the lowest enzyme activity, suggesting that the GBA mutation accelerates the pathological condition [48-50]. The gene discussed is GBA1; the disease is Parkinson disease.